Published trade mark details for 2034561

This information was published on 2019-09-03T14:52:57 for IP Right Filed Published.

Field	Value
(210)	2034561
(220)	03 Sep 2019
(511) (510)	Class 1 Genetic test kits for the detection and analysis of minimal residual disease in blood cancers; genetic analysis test kits containing reagents for detecting, quantitating and characterizing immune cells in a biological sample for scientific research purposes; kits comprising primarily reagents, assays, enzymes and/or nucleotides for genetic research; chemical reagents for genetic research Class 42 Providing medical diagnostic assays and diagnostic and prognostic testing for residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; scientific and medical research and development services; providing medical and scientific research information in the fields of pharmaceuticals and genetics; medical and scientific research in the field of cancer treatment and diagnosis
(540)
(730)	Adaptive Biotechnologies Corporation
(750)	AJ Park

 

Find out more about publications on the About page.